Mylan Pharmaceuticals Private Limited entered into a agreement to acquire off-patent branded and generic established medicines business from Pfizer Limited (BSE:500680) for INR 1.8 billion on September 30, 2021. The transaction is subject to fulfilment of certain conditions, including regulatory approval.